Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Westervelt

Showing results (311-320 of 359) with videos related to

Pageof 36
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|October 22, 2013
Myeloid growth factorsJeffrey Crawford, James Armitage, Lodovico Balducci, et al.
Blood Advances|June 20, 2023
Genomic landscape of TP53-mutated myeloid malignanciesHaley J Abel, Karolyn A Oetjen, Christopher A Miller, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 13, 2013
Myelodysplastic syndromes: clinical practice guidelines in oncologyPeter L Greenberg, Eyal Attar, John M Bennett, et al.
Leukemia|October 15, 2016
Dynamic changes in the clonal structure of MDS and AML in response to epigenetic therapyG L Uy, E J Duncavage, G S Chang, et al.
Nature Communications|February 2, 2018
Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potentialTerrence N Wong, Christopher A Miller, Matthew R M Jotte, et al.
Blood|November 19, 2021
Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapyMelissa M Berrien-Elliott, Michelle Becker-Hapak, Amanda F Cashen, et al.
Nature|December 10, 2014
Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemiaTerrence N Wong, Giridharan Ramsingh, Andrew L Young, et al.
Blood|February 22, 2018
First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantationRizwan Romee, Sarah Cooley, Melissa M Berrien-Elliott, et al.
Transplantation and Cellular Therapy|November 10, 2025
Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: BMT CTN 1702 TrialJason G Dehn, Brent Logan, Stephanie J Lee, et al.
Blood|February 14, 2008
Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemiaMichael H Tomasson, Zhifu Xiang, Richard Walgren, et al.
Pageof 36

Showing results (311-320 of 359) with videos related to

Sort By:
Pageof 36
Journal of the National Comprehensive Cancer Network : JNCCN|October 22, 2013
Myeloid growth factorsJeffrey Crawford, James Armitage, Lodovico Balducci, et al.
Blood Advances|June 20, 2023
Genomic landscape of TP53-mutated myeloid malignanciesHaley J Abel, Karolyn A Oetjen, Christopher A Miller, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 13, 2013
Myelodysplastic syndromes: clinical practice guidelines in oncologyPeter L Greenberg, Eyal Attar, John M Bennett, et al.
Leukemia|October 15, 2016
Dynamic changes in the clonal structure of MDS and AML in response to epigenetic therapyG L Uy, E J Duncavage, G S Chang, et al.
Nature Communications|February 2, 2018
Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potentialTerrence N Wong, Christopher A Miller, Matthew R M Jotte, et al.
Blood|November 19, 2021
Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapyMelissa M Berrien-Elliott, Michelle Becker-Hapak, Amanda F Cashen, et al.
Nature|December 10, 2014
Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemiaTerrence N Wong, Giridharan Ramsingh, Andrew L Young, et al.
Blood|February 22, 2018
First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantationRizwan Romee, Sarah Cooley, Melissa M Berrien-Elliott, et al.
Transplantation and Cellular Therapy|November 10, 2025
Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: BMT CTN 1702 TrialJason G Dehn, Brent Logan, Stephanie J Lee, et al.
Blood|February 14, 2008
Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemiaMichael H Tomasson, Zhifu Xiang, Richard Walgren, et al.
Pageof 36